The efficacy and safety of modified FOLFIRINOX for unresectable advanced pancreatic cancer in elderly versus young patients: A multicenter retrospective cohort study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The efficacy and safety of modified FOLFIRINOX for unresectable advanced pancreatic cancer in elderly versus young patients: A multicenter retrospective cohort study

Published:2022-12 Issue:8 Volume:22 Page:1134-1140
ISSN:1424-3903
Container-title:Pancreatology
language:en
Short-container-title:Pancreatology

Author:

Tezuka Ryuichi^ORCID,Iwashita Takuji^ORCID,Uemura Shinya,Senju Akihiko,Yoshida Kensaku,Maruta Akinori,Iwata Keisuke,Shimizu Masahito^ORCID

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology,Endocrinology, Diabetes and Metabolism

Reference20 articles.

1. Cancer statistics, 2021;Siegel;CA Cancer J Clin,2021

2. Population-based survival of cancer patients diagnosed between 1993 and 1999 in Japan: a chronological and international comparative study;Matsuda;Jpn J Clin Oncol,2010

3. Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

4. Signal crosstalk and induced resistance: straddling the line between cost and benefit;Bostock;Annu Rev Phytopathol,2005

5. Improvement of long-term outcomes in pancreatic cancer and its associated factors within the gemcitabine era: a collaborative retrospective multicenter clinical review of 1,082 patients;Kuroda;BMC Gastroenterol,2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP